These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 33009982)

  • 1. Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility.
    Golchin A
    Stem Cell Rev Rep; 2021 Feb; 17(1):56-62. PubMed ID: 33009982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19.
    Majolo F; da Silva GL; Vieira L; Timmers LFSM; Laufer S; Goettert MI
    Stem Cell Rev Rep; 2021 Feb; 17(1):44-55. PubMed ID: 32827081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.
    Verma YK; Verma R; Tyagi N; Behl A; Kumar S; Gangenahalli GU
    Stem Cell Rev Rep; 2021 Feb; 17(1):113-131. PubMed ID: 32920752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
    Cheng X; Jiang M; Long L; Meng J
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
    [No Abstract]   [Full Text] [Related]  

  • 6. Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study.
    Dauletova M; Hafsan H; Mahhengam N; Zekiy AO; Ahmadi M; Siahmansouri H
    Clin Immunol; 2021 May; 226():108712. PubMed ID: 33684527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients.
    Esquivel D; Mishra R; Soni P; Seetharaman R; Mahmood A; Srivastava A
    Stem Cell Rev Rep; 2021 Feb; 17(1):144-152. PubMed ID: 32740890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises.
    Rezakhani L; Kelishadrokhi AF; Soleimanizadeh A; Rahmati S
    Chem Phys Lipids; 2021 Jan; 234():105009. PubMed ID: 33189639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
    Can A; Coskun H
    Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19.
    Rocha JLM; de Oliveira WCF; Noronha NC; Dos Santos NCD; Covas DT; Picanço-Castro V; Swiech K; Malmegrim KCR
    Stem Cell Rev Rep; 2021 Feb; 17(1):71-93. PubMed ID: 32895900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
    Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR
    J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications.
    Chen L; Qu J; Kalyani FS; Zhang Q; Fan L; Fang Y; Li Y; Xiang C
    Cell Mol Life Sci; 2022 Feb; 79(3):142. PubMed ID: 35187617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis.
    Li Z; Niu S; Guo B; Gao T; Wang L; Wang Y; Wang L; Tan Y; Wu J; Hao J
    Cell Prolif; 2020 Dec; 53(12):e12939. PubMed ID: 33098357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment.
    Younis NK; Zareef RO; Maktabi MAN; Mahfouz R
    Genet Test Mol Biomarkers; 2021 Feb; 25(2):85-101. PubMed ID: 33596144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Atluri S; Manchikanti L; Hirsch JA
    Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Therapy: A Promising Approach in Treatment of COVID-19.
    Abbaspanah B; Abroun S; Zarrabi M; Mozdgir A; Mollanouri M
    Curr Stem Cell Res Ther; 2021; 16(4):406-413. PubMed ID: 33045970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19.
    Pinky ; Gupta S; Krishnakumar V; Sharma Y; Dinda AK; Mohanty S
    Stem Cell Rev Rep; 2021 Feb; 17(1):33-43. PubMed ID: 32661867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients.
    Raghav A; Khan ZA; Upadhayay VK; Tripathi P; Gautam KA; Mishra BK; Ahmad J; Jeong GB
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises.
    Basiri A; Pazhouhnia Z; Beheshtizadeh N; Hoseinpour M; Saghazadeh A; Rezaei N
    Stem Cell Rev Rep; 2021 Feb; 17(1):163-175. PubMed ID: 32564256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.